02158nam a2200409 i 4500001001300000003000600013005001700019007001400036008004100050040002300091042000800114043001200122050002200134074001900156086002300175088009000198110010700288240004200395245026000437246003100697264006000728300002600788336002600814337002700840338003100867500003600898500010800934504004101042500002601083500002501109533010701134650006201241650005901303655003301362776018501395776016801580ocn960810608OCoLC20161111130803.0he bmb024bbca161017s2016 dcu bb f000 0 eng c aGPObengerdacGPO apcc an-us---14aKF27b.E553 2014z a1019-B-01 (MF)0 aY 4.C 73/8:113-171 aSerial no. 113-171 (United States. Congress. House. Committee on Energy and Commerce)1 aUnited States.bCongress.bHouse.bCommittee on Energy and Commerce.bSubcommittee on Health,eauthor.10a21st century cures (2014 September 9)10a21st century cures :bexamining the regulation of laboratory-developed tests : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, September 9, 2014.3 aTwenty-first century cures 1aWashington :bU.S. Government Publishing Office,c2016. av, 178 pages ;c24 cm atextbtxt2rdacontent amicroformbh2rdamedia amicrofichebhe2rdacarrier aShipping list no.: 2016-0177-M. aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office. aIncludes bibliographical references. a"Serial No. 113-171." aCRDP Project record. aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2016]e2 microfiches : negative. 0aDiagnosis, LaboratoryxSafety regulationszUnited States. 0aClinical chemistryxSafety regulationszUnited States. 7aLegislative hearings.2lcgft08iPrint version:aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.s21st century cures (2014 September 9)w(DLC) 2015464828w(OCoLC)94653671608iOnline version:aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.s21st century cures (2014 September 9)w(OCoLC)945978675